tandospirone has been researched along with Depressive Disorder, Major in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, J; Si, T; Su, Y; Wang, C; Wang, X; Xu, Y; Yang, F; Yu, X; Yuan, Y | 1 |
| Kanba, S; Yagi, G; Yamada, K | 1 |
2 trial(s) available for tandospirone and Depressive Disorder, Major
| Article | Year |
|---|---|
Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoindoles; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Pyrimidines; Selective Serotonin Reuptake Inhibitors | 2018 |
Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Middle Aged; Personality Inventory; Piperazines; Prolactin; Pyrimidines; Serotonin Receptor Agonists; Treatment Outcome | 2003 |